학술논문
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
Document Type
article
Author
Dalmasso, B; Pastorino, L; Nathan, V; Shah, NN; Palmer, JM; Howlie, M; Johansson, PA; Freedman, ND; Carter, BD; Beane-Freeman, L; Hicks, B; Molven, A; Helgadottir, H; Sankar, A; Tsao, H; Stratigos, AJ; Helsing, P; Van Doorn, R; Gruis, NA; Visser, M; Wadt, KAW; Mann, G; Holland, EA; Nagore, E; Potrony, M; Puig, S; Menin, C; Peris, K; Fargnoli, MC; Calista, D; Soufir, N; Harland, M; Bishop, T; Kanetsky, PA; Elder, DE; Andreotti, V; Vanni, I; Bruno, W; Höiom, V; Tucker, MA; Yang, XR; Andresen, PA; Adams, DJ; Landi, MT; Hayward, NK; Goldstein, AM; Ghiorzo, P
Source
Genetics in Medicine. 23(11)
Subject
Language
Abstract
PurposeAtaxia-Telangiectasia Mutated (ATM) has been implicated in the risk of several cancers, but establishing a causal relationship is often challenging. Although ATM single-nucleotide polymorphisms have been linked to melanoma, few functional alleles have been identified. Therefore, ATM impact on melanoma predisposition is unclear.MethodsFrom 22 American, Australian, and European sites, we collected 2,104 familial, multiple primary (MPM), and sporadic melanoma cases who underwent ATM genotyping via panel, exome, or genome sequencing, and compared the allele frequency (AF) of selected ATM variants classified as loss-of-function (LOF) and variants of uncertain significance (VUS) between this cohort and the gnomAD non-Finnish European (NFE) data set.ResultsLOF variants were more represented in our study cohort than in gnomAD NFE, both in all (AF = 0.005 and 0.002, OR = 2.6, 95% CI = 1.56-4.11, p